Biochemistry, Genetics and Molecular Biology
Cell Cycle
100%
RNA Sequence
100%
Cytotoxicity
100%
Biological Functions
100%
DNA Damage
100%
Cell Cycle Arrest
100%
Upregulation
100%
Calcium Transport
100%
Mitogen-Activated Protein Kinase
100%
Agonist
100%
Cyclic Adenosine Monophosphate
100%
High-Performance Liquid Chromatography
100%
Tumor Volume
100%
G1 Phase
100%
Cell Cycle Checkpoint
100%
Messenger RNA
100%
Immunoblotting
100%
Programmed Cell Death
100%
Immunology and Microbiology
Xenograft
100%
RNA Sequence
100%
Cytotoxicity
100%
Upregulation
100%
Western Blot
100%
High Performance Liquid Chromatography
100%
Cell Cycle
100%
DNA Damage
100%
Biological Functions
100%
Calcium Transport
100%
Cell Cycle Arrest
100%
Cell Cycle Checkpoint
100%
Tumor Volume
100%
Cell Cycle G1 Phase
100%
Agonist
100%
Programmed Cell Death
100%
Medicine and Dentistry
Glioblastoma
100%
Receptor
100%
Orphan
100%
Cell Signaling Pathway
50%
Neoplasm
25%
RNA Sequence
25%
Xenograft
25%
In Vitro
25%
Biological Marker
25%
Cytotoxicity
25%
Programmed Cell Death
25%
Targeted Therapy
25%
Brain Cancer
25%
Upregulation
25%
Histopathology
25%
Cell Cycle
25%
DNA Damage
25%
Immunoblotting
25%
Cyclic AMP
25%
Mitogen-Activated Protein Kinase
25%
High-Performance Liquid Chromatography
25%
Biological Functions
25%
Tumor Regression
25%
G1 Phase
25%
Calcium Transport
25%
Cell Cycle Arrest
25%
Cell Cycle Checkpoint
25%
Messenger RNA
25%
Keyphrases
Glioblastoma
100%
GPR17
100%
GBM Cells
33%
Signaling Pathway
22%
Endogenous Expression
22%
In Vivo Analysis
11%
Quantitative PCR
11%
Wild Mice
11%
Acute Toxicity
11%
Cytotoxicity
11%
DNA Damage
11%
RNA Sequencing (RNA-seq)
11%
Biological Function
11%
G Protein-coupled Receptor
11%
Tion
11%
Targeted Therapy
11%
Tumor Regression
11%
Improved Survival
11%
Induced Apoptosis
11%
Cell Cycle Arrest
11%
Brain Cancer
11%
Receptor Signaling
11%
Novel Therapies
11%
Immunoblotting
11%
Calcium Flux
11%
Xenograft Model
11%
Signaling Activation
11%
Cyclic Adenosine Monophosphate (cAMP)
11%
Chal
11%
Current Therapies
11%
Predictive Biomarker
11%
Patient-derived Xenograft
11%
ERK MAPK
11%
Stoppages
11%
Tumor Volume
11%
GPR17 Receptor
11%
Mesenchymal Subtype
11%
In Vitro Activation
11%
Encoded Protein
11%
Active Signaling
11%
Functional Receptor
11%
G1 Phase
11%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Glioblastoma
100%
Biological Marker
25%
High Performance Liquid Chromatography
25%
Western Blot
25%
Neoplasm
25%
Tumor Regression
25%
Brain Cancer
25%
Cyclic AMP
25%
RNA-Sequencing
25%
Cytotoxicity
25%
Messenger RNA
25%